Evidence map›Paper›PMID 41282824›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Geography, Ancestry, Age and Sex Shape Somatic Autosomal Mosaic Chromosomal Alterations in Blood.

Jasmine Ryu Won Kang, Yeekyung June Kim, Kimberly Skead, David Soave, Jonathan Evans, Vanessa Bruat, Michelle P Harwood, Quaid Morris, Enock Matovu, Julius Mulindwa and 7 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jasmine Ryu Won KangOntario Institute for Cancer Research; Toronto, Ontario, Canada.
Yeekyung June KimOntario Institute for Cancer Research; Toronto, Ontario, Canada.
Kimberly SkeadOntario Institute for Cancer Research; Toronto, Ontario, Canada.
David SoaveOntario Institute for Cancer Research; Toronto, Ontario, Canada.
Jonathan EvansDivision of Human Genetics, National Health Laboratory Service and School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; Johannesburg, South Africa.
Vanessa BruatOntario Institute for Cancer Research; Toronto, Ontario, Canada.
Michelle P HarwoodOntario Institute for Cancer Research; Toronto, Ontario, Canada.
Quaid MorrisVector Institute; Toronto, Ontario, Canada.
Enock MatovuCollege of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University; Kampala, Uganda.
Julius MulindwaCollege of Veterinary Medicine, Animal Resources and Biosecurity, Makerere University; Kampala, Uganda.
Harry NoyesSchool of Biological Sciences, University of Liverpool; Liverpool United Kingdom.
Annette McLeodSchool of Biodiversity, One Health & Veterinary Medicine, University of Glasgow; Glasgow, United Kingdom.
Scott HazelhurstSydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of Witwatersrand; Johannesburg, South Africa.
Zane LombardDivision of Human Genetics, National Health Laboratory Service and School of Pathology, Faculty of Health Sciences, University of the Witwatersrand; Johannesburg, South Africa.
Michele RamsaySydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of Witwatersrand; Johannesburg, South Africa.
Marie-Julie FaveOntario Institute for Cancer Research; Toronto, Ontario, Canada.
Philip AwadallaDepartment of Molecular Genetics, University of Toronto; Toronto, Ontario, Canada.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Shared Core: Biobanking, Bioinformatics and Data ManagementU54HG006938 · NHGRI · WITS HEALTH CONSORTIUM (PTY), LTD · PI RAMSAY, MICHELE MICHELE · 2012 to 2022
$12.2M
NCI NIH HHS P30 CA008748NHGRI NIH HHS U54 HG006938
6 · The paper itself

Abstract

Clonal hematopoiesis, through the age-associated accumulation of somatic mutations in blood, is strongly associated with hematological malignancies and other chronic diseases. These mutations have largely been characterized in individuals of European ancestry or environments, and consequently, it remains unclear how mutation-recurrence patterns vary across populations of different histories or non-European ancestries. Here, we evaluate how variation in geography, ancestry, genetics and sex shape the prevalence of mosaic chromosomal alterations (mCAs) among 47,369 individuals from the Canadian Partnership for Tomorrow's Health, including a founding population cohort in Quebec, and 13,562 individuals from within South, Central, West and East Africa though the H3Africa consortium. We identified autosomal mCA hotspots that were ancestry- and sex-specific, mapped novel ancestry-specific germline variants associated with autosomal mCA prevalence, and estimated heritability rates to quantify the germline genetic contribution to autosomal mCA variance. We also showed how mCAs impact blood transcriptomes, implicating stabilizing selection as a mechanism by which copy number gain mutations are tolerated in healthy blood. Collectively, mapping the landscape of autosomal mCAs in populations of diverse ancestry illustrates similarities but also highlights important ancestry, geographic, and sex-specific differences.

Indexed as

Africaancestry-specific variationblood transcriptomeclonal hematopoiesismosaic chromosomal alterationsmutational hotspotspopulation genomicssomatic mutations

Identifiers

PMID41282824
PMCPMC12633608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.